Literature DB >> 17160023

Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells.

E A Burwell1, G P McCarty, L A Simpson, K A Thompson, D M Loeb.   

Abstract

The role of WT1 (Wilm's tumor suppressor gene) in breast cancer is controversial, with evidence for both tumor-promoting and tumor-suppressing activities. In order to address this question, we expressed different WT1 isoforms in the mammary epithelial cell line H16N-2, which does not express endogenous WT1. Cells were stably transfected with either WT1 (-Ex5/-KTS) or WT1 (+Ex5/+KTS) under the control of the inducible metallothionein promoter. Induction of WT1 (-Ex5/-KTS) upregulated p21, causing a slowing of proliferation and a G2-phase cell cycle arrest. In artificial basement membrane, the WT1 (-Ex5/-KTS) isoform promoted the appearance of highly organized acinar cellular aggregates. In contrast, WT1 (+Ex5/+KTS) had no effect on p21 or proliferation, but rather caused an epithelial-mesenchymal transition and a redistribution of E-cadherin from the cell membrane to the cytoplasm. This isoform also causes the cellular aggregates growing in artificial basement membrane to appear significantly less organized than control cells. Thus, different WT1 isoforms have distinct effects in this cell line, suggesting that depending on the ratio of WT1 isoform expression in mammary epithelial cells, WT1 could function to either promote or suppress a transformed phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160023     DOI: 10.1038/sj.onc.1210127

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms' tumor suppressor WT1.

Authors:  Lianguo Kang; Lei Wang; Zhao-Yi Wang
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

2.  HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.

Authors:  Hui Li; Shuai Hou; Tian Hao; Sikandar Azam; Caigang Liu; Lei Shi; Haixin Lei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  The Wilms' tumor suppressor WT1 is associated with melanoma proliferation.

Authors:  Nicole Wagner; John Panelos; Daniela Massi; Kay-Dietrich Wagner
Journal:  Pflugers Arch       Date:  2007-10-03       Impact factor: 3.657

4.  The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells.

Authors:  Lei Wang; Zhao-Yi Wang
Journal:  Oncol Rep       Date:  2010-04       Impact factor: 3.906

5.  Wilms' tumour protein Wt1 stimulates transcription of the gene encoding vascular endothelial cadherin.

Authors:  Karin M Kirschner; Lina K Sciesielski; Holger Scholz
Journal:  Pflugers Arch       Date:  2010-09-02       Impact factor: 3.657

6.  The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance.

Authors:  Lei Wang; Xintian Zhang; Zhao-Yi Wang
Journal:  Anticancer Res       Date:  2010-09       Impact factor: 2.480

Review 7.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

8.  Transcription factor Sp3 knockout mice display serious cardiac malformations.

Authors:  Pieter Fokko van Loo; Edris A F Mahtab; Lambertus J Wisse; Jun Hou; Frank Grosveld; Guntram Suske; Sjaak Philipsen; Adriana C Gittenberger-de Groot
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

9.  Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis.

Authors:  Suman Karki; Ranu Surolia; Thomas David Hock; Purusotham Guroji; Jason S Zolak; Ryan Duggal; Tong Ye; Victor J Thannickal; Veena B Antony
Journal:  FASEB J       Date:  2013-11-21       Impact factor: 5.191

10.  The Wilms' tumor suppressor WT1 inhibits malignant progression of neoplastigenic mammary epithelial cells.

Authors:  Lei Wang; Zhao-Yi Wang
Journal:  Anticancer Res       Date:  2008 Jul-Aug       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.